Meloxicam Fast Disintegrating Tablet via Freeze Drying
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current meloxicam oral dosage forms face challenges in ease of administration and patient compliance due to slow disintegration times, which can lead to inadequate relief for arthritis and pain symptoms.
Innovation Solution
A fast disintegrating oral dosage form of meloxicam is developed, comprising a therapeutically effective amount of meloxicam or its pharmaceutically acceptable salt, combined with a matrix former and a dispersing agent, frozen to form a solid tablet that disintegrates rapidly in the oral cavity, facilitating quick drug release.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If conventional oral dosage forms of meloxicam are used, then the drug can be administered orally, but the disintegration time is slow which reduces patient compliance and ease of administration
Solution Approach 1:
The patent changes the physical and chemical parameters of the dosage form by incorporating specific excipients (dispersing agents, matrix formers, surfactants) and controlling particle size distribution, moisture content, and compressibility characteristics to achieve rapid disintegration within 30 seconds while maintaining oral administrability
Solution Approach 2:
The patent uses composite material formulation combining meloxicam with multiple excipients including dispersing agents (crospovidone, sodium starch glycolate), matrix formers (microcrystalline cellulose, mannitol), and surfactants to create a tablet structure that disintegrates rapidly while maintaining structural integrity for oral administration
2Ease of operation
If conventional oral dosage forms of meloxicam are used, then the drug can be administered orally, but the disintegration is slow which reduces patient compliance
Solution Approach 1:
The patent optimizes parameters including particle size (D10, D50, D90 specifications), moisture content (0.5-5%), and excipient ratios to achieve disintegration time of 30 seconds or less, thereby improving patient compliance through rapid action while maintaining oral dosing convenience
Solution Approach 2:
The patent performs preliminary actions during manufacturing by pre-mixing excipients with specific functional properties, pre-compression, and controlled drying to ensure the tablet structure is primed for rapid disintegration upon contact with oral fluids, thus improving compliance without extending administration time
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The fast disintegrating dosage form ensures rapid drug release, improving bioavailability and patient compliance by disintegrating within seconds to minutes, providing effective relief for arthritis and pain symptoms.
Implementation Method 1
freezing said mixture in said trays so as to form a solid state of the mixtures
Data Source
AI summary
The invention provides pharmaceutical compositions comprising a therapeutically effective amount of meloxicam, or a pharmaceutically acceptable salt thereof, wherein the pharmaceutical compositions are in the form of a fast disintegrating dosage form suitable for releasing meloxicam rapidly in the oral cavity. Also provided are processes for preparing a pharmaceutical composition of the invention. Further provided are methods of treating arthritis or pain in a subject in need thereof, the method comprising orally administering to the subject a therapeutically effective amount of a pharmaceutical composition according to the invention.